Article Text

Download PDFPDF

Systemic inflammation and decline in lung function in a general population: a prospective study
Free
  1. Andrew W Fogarty1,
  2. Stuart Jones3,
  3. John R Britton1,
  4. Sarah A Lewis2,
  5. Tricia M McKeever1
  1. 1Division of Epidemiology and Public Health, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham, UK
  2. 2Division of Respiratory Medicine, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham, UK
  3. 3Department of Clinical Chemistry, City Hospital, Nottingham, UK
  1. Correspondence to:
    Dr Andrew Fogarty
    Division of Epidemiology and Public Health, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK; andrew.fogarty{at}nottingham.ac.uk

Abstract

Background: An increase in levels of C-reactive protein (CRP), a marker of systemic inflammation, is associated with reduced forced expiratory volume in 1 s (FEV1), supporting the hypothesis that the pathophysiology of chronic obstructive pulmonary disease has a systemic inflammatory component. However, few large studies have assessed the relationship between systemic inflammation as measured by CRP and decline in lung function prospectively in a randomly selected population.

Methods: In 1991, data were collected on FEV1 and forced vital capacity (FVC) and a blood sample was taken from 2442 randomly selected adults in a community-based cohort. In 2000 these measures were repeated in 1301 individuals. The level of serum CRP was analysed in these samples from 1991 and 2000.

Results: In cross-sectional analyses of data from 1991 and 2000, serum CRP levels were inversely related to FEV1 and FVC. After adjustment for smoking and other confounders, the difference in FEV1 was reduced by −9 ml (95% CI –13 to –5) and –7 ml (95% CI –13 to –2) for each mg/l increment in serum CRP in 1991 and 2000, respectively. There was no significant association between baseline serum CRP levels and decline in FEV1 and FVC over 9 years.

Conclusions: Although serum CRP levels are inversely associated with lung function in cross-sectional studies, there was no effect of a marker of systemic inflammation on decline in lung function over 9 years.

  • BMI, body mass index
  • COPD, chronic obstructive pulmonary disease
  • CRP, C-reactive protein
  • FEV1, forced expiratory volume in 1 s
  • FVC, forced vital capacity

Statistics from Altmetric.com

Footnotes

  • Published Online First 24 January 2007

  • Tricia McKeever is funded by the Wellcome Trust. The study was funded by Asthma UK, the British Lung Foundation and the University of Nottingham.

  • Competing interests: None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles